To evaluate the risk associated with AD and further validate the predictive efficacy of the three hub genes (MAP4, GPT, and HIRIP3), we employed the “rms” package to construct a nomogram incorporating these genes (Figure 3A). This evidence concerns the gene MAP4 and Alzheimer disease.